Search clinical trials for: TC-5214

Total 3875 results

Targacept Inc.

Completed

Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder

Overactive Bladder

United States
Targacept Inc.

Terminated

TC-5214 as Augmentation Therapy in Patients With Refractory Hypertension

Refractory Hypertension

United States
AstraZeneca

Completed

A Study to Assess Safety and Tolerability as Well as Absorption and Excretion of TC-5214 in Medically Stable Elderly Subjects

Elderly Subjects 65 Years and Older, Healthy or With a Stable Disease and Treatment.

Sweden
AstraZeneca

Completed

A Study of Single and Multiple Ascending Doses of TC-5214 in Japanese Healthy Elderly Male and Female Volunteers

Healthy

Japan
Atacama Therapeutics

Completed

Exploratory Study to Assess the Efficacy and Safety of TC-5214 in the Treatment of Subjects With Palmar Hyperhidrosis

Palmar Hyperhidrosis

United States
AstraZeneca

Completed

Study in Healthy Subjects to Measure the Effects of Food on the Pharmacokinetics of TC-5214 (TC-5214)

Healthy Subjects

United States
AstraZeneca

Completed

To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function

Renal Impairment | Healthy Volunteers | Pharmacokinetics | Patients

United States
AstraZeneca
Targacept Inc.

Completed

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)

Depression | Major Depressive Disorder

United States, India
AstraZeneca

Withdrawn

Study in Healthy Recreational Polydrug Users to Measure the Abuse Potential of TC-5214 (TC-5214)

Healthy | Drug Abuse
AstraZeneca

Completed

To Investigate Safety, Tolerability and Pharmacokinetics of TC-5214 in Healthy Male Japanese Subjects

Healthy
AstraZeneca

Completed

To Investigate the Safety and Tolerability of TC-5214 Following Oral Administration of Multiple Doses for up to 8 Days

Healthy

United States
AstraZeneca
Targacept Inc.

Completed

A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Depression | Major Depressive Disorder | MDD

United States, Puerto Rico
AstraZeneca
Targacept Inc.

Completed

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.

Major Depressive Disorder

Croatia, Brazil, Bulgaria, France, Poland, Russian Federation, South Africa, Hungary, Romania, Ukraine, Argentina, Chile, Slovakia, Colombia, Germany, Serbia, Spain
AstraZeneca

Terminated

To Determine Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors) in Patients With Chronic Hypertension

Chronic Hypertension

United Kingdom, Germany, United States
AstraZeneca
Targacept Inc.

Completed

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Depression | Major Depressive Disorder

United States, India, Puerto Rico
AstraZeneca
Targacept Inc.

Completed

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Depression | Major Depressive Disorder

Sweden, Czech Republic, Poland, Germany, Estonia, Latvia, Lithuania, Finland, France, Hungary
Targacept Inc.

Completed

TC-5214 as add-on the Treatment of Major Depressive Disorder

Depression | Major Depressive Disorder

United States, India
Assiut University

Unknown

Split Renal Function Using 99mTc-DTPA Versus 99mTc-DMSA in Kidney Patients of Wide Age Ranges.

The Difference in Estimation of Split Renal Function Using the Two Radiopharmaceuticals:Tc-99m DTPA & Tc-99m DMSA in Kidney Patients
AstraZeneca

Terminated

Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Heart

Healthy Male

United Kingdom
AstraZeneca

Terminated

A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.

Major Depressive Disorder

United States, Estonia, Japan, Finland, India
Clear Guide Medical
Johns Hopkins University

Unknown

Ultrasound-CT Fusion System for Interventional Radiology Procedures

CT Guided Biopsy | CT Guided Drain Placement Within the Abdomen or Pelvis | CT Guided Injection of Muscle or Nerve Within the Pelvis

United States
Atacama Therapeutics

Active, not recruiting

Clinical Study to Assess the Efficacy and Safety of AT-5214 in the Treatment of Subjects With Palmar Hyperhidrosis

Hyperhidrosis | Palmar Hyperhidrosis

United States
CellSight Technologies, Inc.
Oregon Health and Science University; Stanford University

Recruiting

A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors

Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefit

United States
Philips Healthcare (Suzhou) Co., Ltd.
The Second Hospital of Nanjing Medical University

Not yet recruiting

Incisive CT Clinica Trial Protocol

CT Images
University Hospital Inselspital, Berne

Recruiting

Assessing Ultra-low Dose PET/CT and CT-less PET Using a Long Axial Field-of-view PET/CT System (ULD-PET)

PET/CT

Switzerland
Wei Li

Recruiting

The Impact of Different Scanning Methods and Reconstruction Algorithms on CT Image Quality

CT Examination of the Abdomen

China
Duke University

Suspended

Assessing Muscle Metabolic Phenotype by MSK Ultrasound

Ultrasound | CT | MuscleSound

United States
Philips (China) Investment CO., LTD
West China Hospital; Ruijin Hospital; Shanghai Changzheng Hospital

Terminated

Spectral CT Clinical Trial Protocol

CT Scanning

China
GE Healthcare
University of Chicago; University of Washington

Recruiting

Clinical Data Collection and Evaluation of ECG-Less Cardiac CT

Cardiac CT

United States
Sir Mortimer B. Davis - Jewish General Hospital

Enrolling by invitation

Fluorocholine PET/CT Basket Trial

Fluorocholine PET/CT

Canada
Seoul National University Hospital

Completed

Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT

Abdominal CT
Lument AB

Terminated

A Randomized, Controlled Trial to Evaluate CT Image Quality Lumentin® 44

Subjects Referred to CT-examination of the Abdomen

Sweden
Lundquist Institute for Biomedical Innovation at...
General Electric

Completed

Comparison of Contrast Agents During CT Angiography (Visipaque)

Contrast Enhancement on Cardiac CT

United States
Washington University School of Medicine
National Cancer Institute (NCI)

Terminated

Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)

PET/CT

United States
Centre Hospitalier Universitaire de Nīmes

Completed

Impact of Reconstruction Method (ASIR, FBP) Used in CT on Bone SPECT/CT Image Quality (AsirTest)

SPECT-CT

France
GE Healthcare

Completed

Clinical Evaluation of a Dual Energy CT System

General CT Imaging
Washington University School of Medicine
Siemens Corporation, Corporate Technology

Recruiting

Gated and Non-Gated Dynamic PET/CT Imaging

Dynamic PET/CT Imaging

United States
Second Affiliated Hospital, School of Medicine,...

Completed

Anatomical Study of Aorta Balloon Occlusion Based on CT Angiography

CT Angiography | Marker; Structural

China
University of Cincinnati
National Cancer Institute (NCI); Ohio Third Frontier

Active, not recruiting

Validating Low FDG Dose PET/CT Compared to Current Standard of Care Dose PET/CT

PET/CT Imaging

United States
National Taiwan University Hospital

Unknown

Balloon-assisted Enteroscopy and Bacteria

Bleeding | Enteritis

Taiwan
The University of Hong Kong

Active, not recruiting

Tai Chi-muscle Power Training for Primary School Children With Developmental Coordination Disorder

Developmental Coordination Disorder

Hong Kong
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Subjects Undergoing Procedure-Type Sedation

Ultrasound | CT Scans | MRIs

United States, Puerto Rico
Far Eastern Memorial Hospital

Completed

Effects of Heart Rates and Variability of Heart Rates on Image Quality of Dual-Source CT Coronary Angiography (DSCT)

Coronary Angiography | CT

Taiwan
Zhongnan Hospital

Recruiting

Integrin αvβ6-targeted PET in Malignant Tumors

Malignant Neoplasm | PET/CT | Integrin αvβ6

China
Yonsei University

Completed

The Incidence and Nature of Adverse Events During Pediatric Sedation for MRI/CT in One Korean University Hospital: Prospective Study

Children Requiring Sedation for MRI/CT

Korea, Republic of
Assiut University

Unknown

Negative Oral Contrast Agents Utilization in PET/CT Studies

PET/CT | Oral Contrast

Egypt
Duke University

Terminated

Patient- and Task-specific Radiation Dose Optimization for Pediatric Abdominopelvic CT Applications

Split Dose CT

United States
Philips Electronics Nederland B.V. acting through...
Leiden University Medical Center

Terminated

Fast Ultra Low Dose CT Interpretation

Thoracic | Ultra-low-dose CT

Netherlands
Daewoong Pharmaceutical Co. LTD.

Unknown

Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients

CT Scanning Patients

Korea, Republic of
Abdul Latif Jameel Poverty Action Lab
Icahn School of Medicine at Mount Sinai

Terminated

Clinical Decision Support (CDS) for Outpatient Radiology Imaging

CT and MR Image Orders

United States

Search clinical trials for: TC-5214

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations